Literature DB >> 32188758

The SCFβ-TrCP E3 Ubiquitin Ligase Regulates Immune Receptor Signaling by Targeting the Negative Regulatory Protein TIPE2.

Yunwei Lou1,2, Meijuan Han1,2, Yaru Song3, Jiateng Zhong4, Wen Zhang2, Youhai H Chen5, Hui Wang6,2.   

Abstract

TNFAIP8-like 2 (TIPE2) is a negative regulator of immune receptor signaling that maintains immune homeostasis. Dysregulated TIPE2 expression has been observed in several types of human immunological disorders. However, how TIPE2 expression is regulated remains to be determined. We report in this study that the SCFβ-TrCP E3 ubiquitin ligase regulates TIPE2 protein abundance by targeting it for ubiquitination and subsequent degradation via the 26S proteasome. Silencing of either cullin-1 or β-TrCP1 resulted in increased levels of TIPE2 in immune cells. TAK1 phosphorylated the Ser3 in the noncanonical degron motif of TIPE2 to trigger its interaction with β-TrCP for subsequent ubiquitination and degradation. Importantly, the amount of TIPE2 protein in immune cells determined the strength of TLR 4-induced signaling and downstream gene expression. Thus, our study has uncovered a mechanism by which SCFβ-TrCP E3 ubiquitin ligase regulates TLR responses.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32188758     DOI: 10.4049/jimmunol.1901142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  TLR2/TLR4-Enhanced TIPE2 Expression Is Involved in Post-Hemorrhagic Shock Mesenteric Lymph-Induced Activation of CD4+T Cells.

Authors:  Hui-Bo Du; Sun-Ban Jiang; Zhen-Ao Zhao; Hong Zhang; Li-Min Zhang; Zhao Wang; Ya-Xiong Guo; Jia-Yi Zhai; Peng Wang; Zi-Gang Zhao; Chun-Yu Niu; Li-Na Jiang
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

2.  Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages.

Authors:  Ziqi Zou; Mengyao Li; Yunlian Zhou; Jiaying Li; Ting Pan; Lihua Lai; Qingqing Wang; Lining Zhang; Qun Wang; Yinjing Song; Yuanyuan Zhang
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

3.  Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.

Authors:  Ching-Tse Ting; Bor-Sen Chen
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

4.  In search of the Aplysia immunome: an in silico study.

Authors:  Nicholas S Kron
Journal:  BMC Genomics       Date:  2022-07-29       Impact factor: 4.547

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.